Slide 1: Annual General Meeting Presentation
JUNE 2023 For personal use only ANNUAL GENERAL MEETING PRESENTATION SKIN ELEMENTS LIMITED ASX:SKN SKIN ELEMENTS LIMITED ABN: 90 608 047 794 and its controlled entities
Slide 2: The Board of Directors
The Board of Directors For personal use only Mr Peter Malone Mr Filippo (Phil) Giglia Mr Stuart Usher Executive Chairman and Chief Independent Non-Executive Independent Non-Executive Executive Officer / Managing Director Director Director and Company Secretary Peter Malone has over 30 years’ Phil Gi
Slide 3: Part One Resolutions
Part One Resolutions Lodged Lodged Lodged Total For Open Against Votes For personal use only Votes 80,044,495 413,268 139,545 80,597,308 Resolution 01 REMUNERATION REPORT % 99.31% 0.51% 0.17% Holders 26 4 3 Votes 170,193,893 413,268 139,545 170,746,706 Resolution 02 APPROVAL OF 10% PLACEMENT % 99.68
Slide 4: Part Two Resolutions
Part Two Resolutions Lodged Lodged Lodged Total For Open Against Votes For personal use only Votes 171,748,438 413,268 85,000 172,246,706 Resolution 05 RATIFICATION OF PRIOR ISSUE OF % 99.71% 0.24% 0.05% OPTIONS - LISTING RULE 7.1 Holders 2 40 4 Votes 171,693,893 467,813 85,000 172,246,706 Resolutio
Slide 5: Biotechnology to Deliver Healthy Lifestyle and Healthy Planet
Biotechnology to Deliver Healthy Lifestyle and Healthy Planet The early 21st century has emphasised the importance of sustainable consumption driven by healthy For personal use only lifestyle and healthy planet. The global embrace of new technologies such as renewable energy, electric vehicles, and
Slide 6: Commitment to Safety and Sustainability
Commitment to Safety and Sustainability Skin Elements was founded on the principle of improving For personal use only health and wellness of people, across the globe, without harming our planet. The company is committed to creating a safe and supportive environment for everyone. We are dedicated to
Slide 7: What we Set Out to Do
What we Set Out to Do The process of research and development of the SE FormulaTM biotechnology followed a broadly three phase process: For personal use only PHASE 1 Investigation into ingredients and processes to prepare prototype formulations to achieve specific criteria PHASE 2 Produce test batch
Slide 8: What we Developed
What we Developed SE FORMULA For personal use only Phase 1, research and development of the SE FormulaTM biotechnology creating a unique antimicrobial process that can be used in many different applications. + Sun Protection Therapeutic Pawpaw Hygiene Disinfectants Soléo Organics was the first appli
Slide 9: Disclaimer
Disclaimer All information, terms and pricing set out in this document is indicative, based on, among other things, market conditions at the time of this writing and is subject to change without notice. This document has been prepared by Skin Elements Limited (SKN). The information contained in this